These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27569987)

  • 1. Benefits of Cognitive Treatments Administered to Patients Affected by Mild Cognitive Impairment/Mild Neurocognitive Disorder.
    Cavallo M; Signorino A; Perucchini ML
    Drug Dev Res; 2016 Dec; 77(8):444-452. PubMed ID: 27569987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment:A Systematic Review and Meta-Analysis.
    Matsunaga S; Fujishiro H; Takechi H
    J Alzheimers Dis; 2019 Aug; 71(2):513-523. PubMed ID: 31424411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
    Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment.
    Sachs-Ericsson N; Blazer DG
    Aging Ment Health; 2015 Jan; 19(1):2-12. PubMed ID: 24914889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
    Popp J; Arlt S
    Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cautious notification and continual monitoring of patients with mild cognitive impairment.
    Odawara T
    Psychogeriatrics; 2012 Jun; 12(2):131-2. PubMed ID: 22712649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
    Roy S; Benedict RH; Drake AS; Weinstock-Guttman B
    CNS Drugs; 2016 Mar; 30(3):209-25. PubMed ID: 26884145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome].
    Gavrilova SI; Fedorova IaB; Gantman ; Kalyn IaB; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):16-20. PubMed ID: 22433803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study.
    Mamikonyan E; Xie SX; Melvin E; Weintraub D
    Mov Disord; 2015 Jun; 30(7):912-8. PubMed ID: 25914281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating cognitive and everyday activity deficits into cognitive interventions in mild dementia and mild cognitive impairment.
    Giebel C; Challis D
    Int J Geriatr Psychiatry; 2015 Jan; 30(1):21-31. PubMed ID: 24990546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicine for Mild Cognitive Impairment and Age Associated Memory Impairment: a review of randomised controlled trials.
    May BH; Yang AW; Zhang AL; Owens MD; Bennett L; Head R; Cobiac L; Li CG; Hugel H; Story DF; Xue CC
    Biogerontology; 2009 Apr; 10(2):109-23. PubMed ID: 18716893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
    Small BJ; Gagnon E; Robinson B
    Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management decisions in mild cognitive impairment.
    Bensadon BA; Odenheimer GL
    Clin Geriatr Med; 2013 Nov; 29(4):847-71. PubMed ID: 24094300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New DSM-V neurocognitive disorders criteria and their impact on diagnostic classifications of mild cognitive impairment and dementia in a memory clinic setting.
    Tay L; Lim WS; Chan M; Ali N; Mahanum S; Chew P; Lim J; Chong MS
    Am J Geriatr Psychiatry; 2015 Aug; 23(8):768-79. PubMed ID: 25728011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil abolishes anticholinergic activity in a patient with amnesia.
    Konishi K; Hori K; Tomioka H; Minegishi G; Tani M; Tanaka H; Akita R; Yokoyama S; Oshio T; Hachisu M
    Pharmacology; 2013; 91(1-2):86-91. PubMed ID: 23258422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature.
    Ribeiz SR; Bassitt DP; Arrais JA; Avila R; Steffens DC; Bottino CM
    CNS Drugs; 2010 Apr; 24(4):303-17. PubMed ID: 20297855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment and its management in older people.
    Eshkoor SA; Hamid TA; Mun CY; Ng CK
    Clin Interv Aging; 2015; 10():687-93. PubMed ID: 25914527
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.